Global Longlife Hospital and Research Limited

As of March 31, 2026, Global Longlife Hospital and Research Limited carries a market capitalization of 143.43M, placing it among publicly traded companies globally. Its enterprise value stands at -26.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Global Longlife Hospital and Research Limited has 10.50M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Global Longlife Hospital and Research Limited maintains a current ratio of 1,691.15, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Global Longlife Hospital and Research Limited's stock has declined approximately 43.67% over the past 52 weeks. The 50-day moving average sits at 12.64, while the 200-day moving average is 14.15.

As of March 31, 2026, Global Longlife Hospital and Research Limited holds 170.17M in cash and equivalents against - - in total debt, resulting in a net debt position of -170.17M. Total book value stands at 237.49M, with working capital of 202.82M providing operational flexibility.